Intralesional Treatment of Keloids
Recruiting
Phase 3
Interventional Study
Scar, Hypertrophic
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Pivotal Trial
This treatment is in the last trial phase before FDA approval.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 – 60
- Sex
- Any
- Trial phase
- Phase 3
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 45 (estimated)
- Sponsor
- Sohag University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Intralesional injection in treatment of keloid
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
Both sex aged 18-60 having keloid
\-
Exclusion Criteria:
* pregnancy , lactation Skin disease
Contacts